In many industrialized countries, with some degree of screening, cervical cancer nowadays is most frequent among women of lower socioeconomic status (SES), partly owing to their lower participation in screening. This study aims to provide support for specification of mass screening policy for cervical cancer by describing relationships between sociodemographic factors and the incidence of cervical cancer in the Netherlands based on geographical differences and by analysing the relationship between SES of neighbourhood and individual tumour characteristics. Municipality-specific, age-adjusted incidence rates for cervical cancer were calculated from the Netherlands Cancer Registry, and data on sociodemographic factors were obtained from Stati...
Background: Time–space incidence maps of the Netherlands indicated differences in incidence of cutan...
With respect to cervical cancer management, Finland and the Netherlands are comparable in relevant c...
In the Netherlands, approximately 2% of all newly diagnosed malignant tumours in women are cancers ...
In many industrialized countries, with some degree of screening, cervical cancer nowadays is most fr...
Introduction: Cervical cancer is a major cause of mortality and morbidity. We aimed to estimate the ...
Introduction: Cervical cancer is a major cause of mortality and morbidity. We aimed to estimate the ...
textabstractIn the Netherlands, approximately 2% of all newly diagnosed malignant tumours in women ...
textabstractWorldwide, cervical cancer is the second most common female malignancy, diagnosed in 500...
To evaluate the effect of population-based cervical cancer screening on the occurrence of cervical c...
Background: Time-space incidence maps of the Netherlands indicated differences in incidence of cutan...
Background: Time-space incidence maps of the Netherlands indicated differences in incidence of cutan...
Background: Time-space incidence maps of the Netherlands indicated differences in incidence of cutan...
Background: Time-space incidence maps of the Netherlands indicated differences in incidence of cutan...
Background: Time-space incidence maps of the Netherlands indicated differences in incidence of cutan...
In the Netherlands, approximately 2% of all newly diagnosed malignant tumours in women are cancers ...
Background: Time–space incidence maps of the Netherlands indicated differences in incidence of cutan...
With respect to cervical cancer management, Finland and the Netherlands are comparable in relevant c...
In the Netherlands, approximately 2% of all newly diagnosed malignant tumours in women are cancers ...
In many industrialized countries, with some degree of screening, cervical cancer nowadays is most fr...
Introduction: Cervical cancer is a major cause of mortality and morbidity. We aimed to estimate the ...
Introduction: Cervical cancer is a major cause of mortality and morbidity. We aimed to estimate the ...
textabstractIn the Netherlands, approximately 2% of all newly diagnosed malignant tumours in women ...
textabstractWorldwide, cervical cancer is the second most common female malignancy, diagnosed in 500...
To evaluate the effect of population-based cervical cancer screening on the occurrence of cervical c...
Background: Time-space incidence maps of the Netherlands indicated differences in incidence of cutan...
Background: Time-space incidence maps of the Netherlands indicated differences in incidence of cutan...
Background: Time-space incidence maps of the Netherlands indicated differences in incidence of cutan...
Background: Time-space incidence maps of the Netherlands indicated differences in incidence of cutan...
Background: Time-space incidence maps of the Netherlands indicated differences in incidence of cutan...
In the Netherlands, approximately 2% of all newly diagnosed malignant tumours in women are cancers ...
Background: Time–space incidence maps of the Netherlands indicated differences in incidence of cutan...
With respect to cervical cancer management, Finland and the Netherlands are comparable in relevant c...
In the Netherlands, approximately 2% of all newly diagnosed malignant tumours in women are cancers ...